AxoGen (AXGN) EBITDA margin US GAAP (year values) |
||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA margin, % | ? | -16.9% | -16.9% | -8.38% | 3.24% | 0.09% | 2.39% | |
| Changes by years, y/y, % | 0pp | +9pp | +12pp | -3pp | ||||
AxoGen. EBITDA margin, %
AxoGen. EBITDA margin, changes, pp
AxoGen (AXGN) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 0.61% | 7.72% | 21.1% | -14.2% | -4.61% | 2.39% | |
| Changes by years, y/y, % | +6pp | +3pp | +17pp | -23pp | -5pp | |||
| Changes by quarters, q/q, % | -8pp | +7pp | +13pp | -35pp | +10pp | |||